Cumberland Pharmaceuticals (CPIX) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 71.83% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -0.17% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -14.68% |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -90.23% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 2,405.06% |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -14.93% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 62.34% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -286.15% |
| 10 | Cumberland Pharmaceuticals | 87.59 Mn | 76.25 Mn | 7.20 Mn | -324.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -324.92% |
| Dec 31, 2025 | 32.31% |
| Sep 30, 2025 | -26.81% |
| Jun 30, 2025 | 33.32% |
| Mar 31, 2025 | 165.61% |
| Dec 31, 2024 | 74.70% |
| Sep 30, 2024 | -44.56% |
| Jun 30, 2024 | -227.89% |
| Mar 31, 2024 | -1,204.25% |
| Dec 31, 2021 | -49.12% |
| Sep 30, 2021 | -42.46% |
| Jun 30, 2021 | -20.41% |
| Mar 31, 2021 | -26.66% |
| Dec 31, 2020 | -59.37% |
| Sep 30, 2020 | -37.23% |
| Jun 30, 2020 | -29.36% |
| Mar 31, 2020 | -37.65% |
| Dec 31, 2019 | 142.38% |
| Sep 30, 2019 | 197.77% |
| Jun 30, 2019 | 324.68% |